GLP-1 Drugs present a promising avenue for intervention: Overlapping risk factors: Given the shared risk factors between diabetes and liver disease, the diabetic drug Ozempic is projected to become the second-highest-grossing treatment for NAFLD and NASH by 2028
The significant GI side effects, major fueling challenges, risk of muscle loss (and lost watts), high cost, and questionable long-term impacts should give any rider pause
Thurlow, L
It is not just about side effect management
Official Details: Medication: Tirzepatide (identical to Mounjaro) Manufacturer: Eli Lilly FDA Approval: November 2023 Approved For: Chronic weight management in adults with obesity or overweight with weight-related conditions Dosing: Once-weekly injection Available Doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg List Price: $1,069 per month (same as Mounjaro) How Zepbound Differs from Mounjaro: The medications are completely identical
What happens if I take my semaglutide too early multiple times